Goldfine A, Faulkner R, Sadashivam V, Omidvar O, Hill J, Jagadeesan S, Sharma A, Yao SL. Results of a Phase 1 Dose-Ranging Trial, and Design of a Phase 2 Trial, of K0706, a Novel C-Abl Tyrosine Kinase Inhibitor for Parkinson’s Disease. (P2.8-047). Neurology Supplement, April 6, 2019 Neurology Supplement
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.